Our investigation in 2023 revealed that antibodies obtained from COVID-19 convalescents and vaccinated donors can hydrolyze six out of nine oligopeptides that correspond to epitopes of the S-protein of SARS-CoV-2 [27]. This evidence concerns the gene PROS1 and COVID-19.